Catalog No.
DHK06899
Description
Sirtratumab vedotin is an ADC consisting of a SLITRK6-directed antibody and Monomethyl auristatin E (MMAE) used for the study of bladder cancer.
Species reactivity
Human
Clonality
Monoclonal
Target
SLITRK6
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
ASG15-ME
Clone ID
Sirtratumab vedotin
For research use only. Not for human or drug use.
